Cargando…
Comprehensive analysis and experimental validation reveal elevated CLCN4 is a promising biomarker in endometrial cancer
Several studies have reported the role of CLCN4 in tumor progression. However, its mechanism remains to be thoroughly studied. The objective of this study was to explore the potential pathogenic role of CLCN4 in endometrial carcinoma (UCEC) with a better understanding of the pathological mechanisms...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522378/ https://www.ncbi.nlm.nih.gov/pubmed/37671947 http://dx.doi.org/10.18632/aging.204994 |